Intellectual Property

Recce Pharmaceuticals currently has four wholly owned patent families, which include over 30 patents or patent applications and are constantly expanding, broadening, and developing the intellectual property portfolio.

Recce is committed to protecting its intellectual property estate of patent rights and trade secrets as well as the potential commercial and/or clinical advantages this protection provides for its proprietary technology.

Recce’s patent portfolio includes issued patents and patent applications in the world’s major markets, including the United States, Europe, Japan, China and Australia.

Patent Familys

Protecting Recce’s unique and highly economical manufacturing process.

 Filed Expiry Status
Australia Australia 2028 Granted
United States of America(USA) USA 2029 Granted
European Union Europe 2028 Granted
Germany Germany 2028 Granted
Spain Spain 2028 Granted
France France 2029 Granted
United Kingdom(Great Britain) United Kingdom 2028 Granted
Italy Italy 2028 Granted
Sweden Sweden 2028 Granted
Japan Japan 2028 Granted
China China 2028 Granted

Protecting Recce’s drug delivery opportunities.

 Filed Expiry Status
Australia Australia 2035 Granted
United States of America(USA) USA 2035 Granted
European Union Europe 2035 Granted
Germany Germany 2035 Granted
Spain Spain 2035 Granted
France France 2035 Granted
United Kingdom(Great Britain) United Kingdom 2035 Granted
Italy Italy 2035 Granted
Sweden Sweden 2035 Granted
Japan Japan 2035 Granted
China China 2035 Pending

Protecting Recce’s anti-viral and anti-cancer applications.

 Filed Expiry Status
Australia Australia 2037 Pending
United States of America(USA) USA 2037 Granted
European Union Europe 2037 Granted
Germany Germany 2037 Granted
Spain Spain 2037 Granted
France France 2037 Granted
United Kingdom(Great Britain) United Kingdom 2037 Granted
Italy Italy 2037 Granted
Sweden Sweden 2037 Granted
Japan Japan 2037 Granted
China China 2037 Granted
hong-kong Hong Kong 2037 Granted

Protecting RECCE® for use on antibiotic and pharmaceutical products and services

 Filed Expiry Status
Australia  Australia 2026 Registered
United States of America(USA)  USA  2026 Registered
European Union  Europe  2026 Registered
Japan  Japan  2026 Registered
China China  2026 Registered

Sign up for news and updates

Receive news and information direct to your inbox.